Major Changes to the board and management team last year was always going to take time, look at the updates compared to previous years in the first half of the year tells you they seem invigorated and bullish. CEO & MD Nigel seemed more confident imo in the recent presentation and to mention that OSL is well funded to at least the end of next calendar year tells you that they are happy with they are seeing in terms of revenue to be received in the next year or so .
Further expansion into markets, approvals , clinical trial updates , TGA , FDA , updates, G-BA process updates , potential take over interest.could be setting this up for a parabolic move. Markets are forward thinking and the stock price performance is going to depend on the quality of high impact news to be released and imo a market cap of over $100 million is realistic from where it is currently trading.
OSL Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)